Clusterin proposed as a marker of aging in blood stem cells
Researchers from the University of Tokyo propose clusterin as a marker of aging-related changes in blood stem cells, which could help track this process over a lifetime.
Source: Clusterin proposed as a marker of aging in blood stem cells (ashpublications.org). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
According to the report, researchers from the University of Tokyo describe clusterin as a marker of aging-related changes in hematopoietic stem cells, the cells that give rise to blood cells. The proposal is that this molecule could make it possible to follow the aging of these cells over a lifetime.
Blood stem cells help maintain the production of blood cells and the immune system, and they are known to change with age. More precise markers of this aging could help scientists understand how age affects the blood and immunity. Even so, a proposed marker needs to be tested in further studies before it has practical use.
What it means
Clusterin appears as a possible biological indicator of aging in blood stem cells. If confirmed, this measure could support research into how age affects the blood and the immune system. It is not yet clear whether it translates into benefits for individual health.
How to read it with care
This result does not replace a consultation. Anyone considering a change in diet, supplements or treatment should talk to a doctor or another qualified health professional.